DRREDDYPharmaceuticals
Dr Reddys Laboratories Ltd — Balance Sheet
₹1254.90
-1.46%
Dr Reddys Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Treasury Shares Number | 0.25 Cr | 0.14 Cr | 0.19 Cr | 0.23 Cr | — |
| Ordinary Shares Number | 83.20 Cr | 83.26 Cr | 83.08 Cr | 82.98 Cr | — |
| Share Issued | 83.45 Cr | 83.41 Cr | 83.26 Cr | 83.21 Cr | — |
| Net Debt | 2.72K Cr | 941.60 Cr | 541.10 Cr | 1.60K Cr | — |
| Total Debt | 4.68K Cr | 2.00K Cr | 1.35K Cr | 3.38K Cr | — |
| Tangible Book Value | 22.48K Cr | 23.93K Cr | 19.59K Cr | 15.89K Cr | — |
| Invested Capital | 37.52K Cr | 29.71K Cr | 24.22K Cr | 22.14K Cr | — |
| Working Capital | 11.97K Cr | 15.20K Cr | 11.84K Cr | 8.78K Cr | — |
| Net Tangible Assets | 22.48K Cr | 23.93K Cr | 19.59K Cr | 15.89K Cr | — |
| Capital Lease Obligations | 492.10 Cr | 349.70 Cr | 228.20 Cr | 296.30 Cr | — |
| Common Stock Equity | 33.34K Cr | 28.05K Cr | 23.10K Cr | 19.05K Cr | — |
| Total Capitalization | 33.72K Cr | 28.43K Cr | 23.10K Cr | 19.43K Cr | — |
| Total Equity Gross Minority Interest | 33.72K Cr | 28.05K Cr | 23.10K Cr | 19.05K Cr | — |
| Minority Interest | 377.80 Cr | 0.00 | — | — | — |
| Stockholders Equity | 33.34K Cr | 28.05K Cr | 23.10K Cr | 19.05K Cr | — |
| Other Equity Interest | 374.00 Cr | 385.90 Cr | 470.70 Cr | 507.20 Cr | — |
| Gains Losses Not Affecting Retained Earnings | 397.90 Cr | 65.30 Cr | 88.60 Cr | 75.50 Cr | — |
| Other Equity Adjustments | 397.90 Cr | 65.30 Cr | 88.60 Cr | 75.50 Cr | — |
| Treasury Stock | 226.40 Cr | 99.10 Cr | 126.90 Cr | 160.10 Cr | — |
| Retained Earnings | 31.58K Cr | 26.53K Cr | 21.56K Cr | 17.57K Cr | — |
| Additional Paid In Capital | 1.13K Cr | 1.09K Cr | 1.02K Cr | 975.70 Cr | — |
| Capital Stock | 83.40 Cr | 83.40 Cr | 83.30 Cr | 83.20 Cr | — |
| Common Stock | 83.40 Cr | 83.40 Cr | 83.30 Cr | 83.20 Cr | — |
| Total Liabilities Net Minority Interest | 15.58K Cr | 10.70K Cr | 9.09K Cr | 10.23K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 2.54K Cr | 1.09K Cr | 501.80 Cr | 828.50 Cr | — |
| Other Non Current Liabilities | 214.10 Cr | 277.60 Cr | 129.30 Cr | 82.50 Cr | — |
| Non Current Deferred Liabilities | 1.53K Cr | 210.20 Cr | 238.80 Cr | 165.70 Cr | — |
| Non Current Deferred Revenue | 116.20 Cr | 119.30 Cr | 155.50 Cr | 159.70 Cr | — |
| Non Current Deferred Taxes Liabilities | 1.41K Cr | 90.90 Cr | 83.30 Cr | 6.00 Cr | — |
| Long Term Debt And Capital Lease Obligation | 786.40 Cr | 599.00 Cr | 127.80 Cr | 574.60 Cr | — |
| Long Term Capital Lease Obligation | 406.40 Cr | 219.00 Cr | 127.80 Cr | 194.60 Cr | — |
| Long Term Debt | 380.00 Cr | 380.00 Cr | — | 380.00 Cr | 380.00 Cr |
| Long Term Provisions | 15.60 Cr | 6.10 Cr | 5.90 Cr | 5.70 Cr | — |
| Current Liabilities | 13.04K Cr | 9.60K Cr | 8.58K Cr | 9.40K Cr | — |
| Other Current Liabilities | 735.50 Cr | 603.40 Cr | 373.90 Cr | 250.30 Cr | — |
| Current Deferred Liabilities | 198.30 Cr | 143.50 Cr | 198.10 Cr | 257.60 Cr | — |
| Current Deferred Revenue | 198.30 Cr | 143.50 Cr | 198.10 Cr | 257.60 Cr | — |
| Current Debt And Capital Lease Obligation | 3.89K Cr | 1.40K Cr | 1.22K Cr | 2.81K Cr | — |
| Current Capital Lease Obligation | 85.70 Cr | 130.70 Cr | 100.40 Cr | 101.70 Cr | — |
| Current Debt | 3.80K Cr | 1.27K Cr | 1.12K Cr | 2.71K Cr | — |
| Line Of Credit | 3.80K Cr | 1.27K Cr | 739.00 Cr | 2.71K Cr | — |
| Current Provisions | 616.80 Cr | 538.30 Cr | 545.40 Cr | 425.80 Cr | — |
| Payables And Accrued Expenses | 7.60K Cr | 6.92K Cr | 6.25K Cr | 5.66K Cr | — |
| Current Accrued Expenses | 2.51K Cr | 2.48K Cr | 2.18K Cr | 2.01K Cr | — |
| Payables | 5.08K Cr | 4.44K Cr | 4.06K Cr | 3.65K Cr | — |
| Other Payable | 2.78K Cr | 2.05K Cr | 2.06K Cr | 1.89K Cr | — |
| Total Tax Payable | 302.80 Cr | 234.20 Cr | 214.40 Cr | 161.50 Cr | — |
| Accounts Payable | 2.01K Cr | 2.15K Cr | 1.79K Cr | 1.60K Cr | — |
| Total Assets | 49.30K Cr | 38.75K Cr | 32.19K Cr | 29.28K Cr | — |
| Total Non Current Assets | 24.29K Cr | 13.95K Cr | 11.76K Cr | 11.10K Cr | — |
| Other Non Current Assets | 22.20 Cr | 88.50 Cr | 13.20 Cr | 22.40 Cr | — |
| Non Current Prepaid Assets | 75.00 Cr | 74.70 Cr | 66.80 Cr | 67.00 Cr | — |
| Non Current Deferred Assets | 1.85K Cr | 1.08K Cr | 719.60 Cr | 820.40 Cr | — |
| Non Current Deferred Taxes Assets | 1.85K Cr | 1.08K Cr | 719.60 Cr | 820.40 Cr | — |
| Non Current Accounts Receivable | 182.10 Cr | 371.80 Cr | 268.70 Cr | 5.40 Cr | — |
| Investments And Advances | 1.52K Cr | 525.50 Cr | 536.20 Cr | 798.60 Cr | — |
| Investmentin Financial Assets | 1.04K Cr | 105.90 Cr | 66.00 Cr | 366.80 Cr | — |
| Available For Sale Securities | 905.00 Cr | 24.90 Cr | 28.20 Cr | 325.60 Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 134.10 Cr | 81.00 Cr | 37.80 Cr | 41.20 Cr | — |
| Long Term Equity Investment | 481.10 Cr | 419.60 Cr | 470.20 Cr | 431.80 Cr | — |
| Goodwill And Other Intangible Assets | 10.86K Cr | 4.12K Cr | 3.51K Cr | 3.17K Cr | — |
| Other Intangible Assets | 9.68K Cr | 3.70K Cr | 3.08K Cr | 2.72K Cr | — |
| Net PPE | 9.78K Cr | 7.69K Cr | 6.65K Cr | 6.22K Cr | — |
| Accumulated Depreciation | -9.26K Cr | -9.33K Cr | -8.58K Cr | -7.98K Cr | — |
| Gross PPE | 19.04K Cr | 17.01K Cr | 15.23K Cr | 14.20K Cr | — |
| Construction In Progress | 2.48K Cr | 1.45K Cr | 995.60 Cr | 1.34K Cr | — |
| Machinery Furniture Equipment | 12.66K Cr | 11.83K Cr | 10.83K Cr | 9.59K Cr | — |
| Buildings And Improvements | 3.47K Cr | 3.30K Cr | 2.97K Cr | 2.84K Cr | — |
| Land And Improvements | 424.30 Cr | 430.90 Cr | 431.80 Cr | 423.30 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 25.01K Cr | 24.80K Cr | 20.43K Cr | 18.19K Cr | — |
| Other Current Assets | 400.20 Cr | 277.10 Cr | 517.50 Cr | 329.30 Cr | — |
| Hedging Assets Current | 55.70 Cr | 16.90 Cr | 123.20 Cr | 190.60 Cr | — |
| Prepaid Assets | 676.80 Cr | 474.90 Cr | 417.60 Cr | 113.80 Cr | — |
| Inventory | 7.11K Cr | 6.36K Cr | 4.87K Cr | 5.09K Cr | — |
| Finished Goods | 2.84K Cr | 2.52K Cr | 2.10K Cr | 2.05K Cr | — |
| Work In Process | 1.65K Cr | 1.42K Cr | 1.17K Cr | 1.29K Cr | — |
| Raw Materials | 2.62K Cr | 2.41K Cr | 1.60K Cr | 1.75K Cr | — |
| Receivables | 10.98K Cr | 9.53K Cr | 8.32K Cr | 8.03K Cr | — |
| Other Receivables | 1.94K Cr | 1.50K Cr | 1.07K Cr | 947.10 Cr | — |
| Accounts Receivable | 9.04K Cr | 8.03K Cr | 7.25K Cr | 6.68K Cr | — |
| Allowance For Doubtful Accounts Receivable | -147.80 Cr | -145.10 Cr | -125.80 Cr | -119.40 Cr | — |
| Gross Accounts Receivable | 9.19K Cr | 8.17K Cr | 7.37K Cr | 6.80K Cr | — |
| Cash Cash Equivalents And Short Term Investments | 5.79K Cr | 8.15K Cr | 6.18K Cr | 4.44K Cr | — |
| Other Short Term Investments | 4.33K Cr | 7.44K Cr | 5.60K Cr | 2.95K Cr | — |
| Cash And Cash Equivalents | 1.47K Cr | 710.70 Cr | 577.90 Cr | 1.49K Cr | — |
| Cash Equivalents | 251.10 Cr | 258.50 Cr | 274.30 Cr | 35.70 Cr | — |
| Cash Financial | 1.21K Cr | 452.20 Cr | 303.60 Cr | 1.45K Cr | — |
| Goodwill | 1.18K Cr | 425.30 Cr | 424.50 Cr | 441.80 Cr | — |
| Other Current Borrowings | — | 1.02K Cr | 380.00 Cr | 887.10 Cr | 1.28K Cr |
| Other Properties | — | 0.30 Cr | 0.30 Cr | — | — |
| Taxes Receivable | — | — | 268.70 Cr | 403.50 Cr | 274.50 Cr |
| Assets Held For Sale Current | — | — | — | 0.00 | 15.10 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Dr Reddys Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.